Pfizer To Seek US Authorisation For 3rd Covid Shot In Children

Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory…
Read More...